Page last updated: 2024-09-02

ecteinascidin 743 and Osteogenic Sarcoma

ecteinascidin 743 has been researched along with Osteogenic Sarcoma in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (20.00)29.6817
2010's7 (70.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Chiba, K; Horiuchi, K; Inoue, M; Ishizaka, T; Matsuhashi, Y; Rikitake, H; Susa, M; Taguchi, E1
Bongiovanni, L; Botti, L; Burocchi, A; Cancila, V; Cappetti, B; Chiodoni, C; Colombo, MP; Galvan, S; Garofalo, C; Manara, MC; Parenza, M; Ratti, C; Sangaletti, S; Scotlandi, K; Torselli, I; Tripodo, C; Valenti, CF1
Aglietta, M; Aliberti, S; Bardelli, A; Bartolini, A; Bertulli, R; Boccone, P; Chiabotto, G; D'Ambrosio, L; D'Incalci, M; Dei Tos, AP; Ferrari, S; Grignani, G; Marchesi, E; Miano, S; Novara, L; Palmerini, E; Piana, R; Picci, P; Pignochino, Y; Pisacane, A; Sangiolo, D; Stacchiotti, S; Tolomeo, F; Zucchetti, M1
Hayashi, K; Igarashi, K; Miwa, S; Takeuchi, A; Tsuchiya, H; Yamamoto, N1
Bouvet, M; Chawla, SP; Hayashi, K; Higuchi, T; Hoffman, RM; Igarashi, K; Kimura, H; Miwa, S; Miyake, K; Oshiro, H; Singh, SR; Sugisawa, N; Tsuchiya, H; Yamamoto, N1
Constantinidou, A; Jones, RL; Loggers, E; Pollack, S; Rodler, E1
Gastaud, L; Ianessi, A; Italiano, A; Le Morvan, V; Pourquier, P; Saâda-Bouzid, E; Thariat, J; Thyss, A1
Budd, GT; Wesolowski, R1
Benini, S; Cerisano, V; D'Incalci, M; Faircloth, G; Manara, MC; Mercuri, M; Perdichizzi, S; Picci, P; Reverter-Branchat, G; Scotlandi, K; Serra, M; Strammiello, R1
Bagatell, R; Demetri, GD; Goorin, AM; Gorlick, R; Guzman, C; Harmon, D; Healey, JH; Huvos, AG; Jimeno, J; Kolb, EA; Laverdiere, C; Maki, RG; Meyers, PA; Ruiz-Casado, A; Supko, JG; Wexler, L1

Reviews

3 review(s) available for ecteinascidin 743 and Osteogenic Sarcoma

ArticleYear
Therapeutic Targets for Bone and Soft-Tissue Sarcomas.
    International journal of molecular sciences, 2019, Jan-04, Volume: 20, Issue:1

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bone Neoplasms; Drug Therapy; Furans; Humans; Immunotherapy, Adoptive; Indazoles; Ipilimumab; Ketones; Nivolumab; Osteosarcoma; Progression-Free Survival; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Sorafenib; Sulfonamides; Trabectedin

2019
The evolution of systemic therapy in sarcoma.
    Expert review of anticancer therapy, 2013, Volume: 13, Issue:2

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chordoma; Deoxycytidine; Dermatofibrosarcoma; Dioxoles; Docetaxel; Drug Resistance, Neoplasm; Gemcitabine; Hemangiosarcoma; Humans; Osteosarcoma; Proteasome Inhibitors; Receptor, IGF Type 1; Sarcoma; Soft Tissue Neoplasms; Taxoids; Tetrahydroisoquinolines; TOR Serine-Threonine Kinases; Trabectedin

2013
Use of chemotherapy for patients with bone and soft-tissue sarcomas.
    Cleveland Clinic journal of medicine, 2010, Volume: 77 Suppl 1

    Topics: Antineoplastic Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Dioxoles; Humans; Muscle Neoplasms; Osteosarcoma; Sarcoma; Tetrahydroisoquinolines; Trabectedin

2010

Trials

2 trial(s) available for ecteinascidin 743 and Osteogenic Sarcoma

ArticleYear
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group.
    The Lancet. Oncology, 2018, Volume: 19, Issue:10

    Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Female; Humans; Italy; Male; Middle Aged; Osteosarcoma; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Progression-Free Survival; Sarcoma; Soft Tissue Neoplasms; Time Factors; Trabectedin

2018
Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma.
    Cancer, 2003, Aug-15, Volume: 98, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Dioxoles; Female; Humans; Isoquinolines; Male; Middle Aged; Osteosarcoma; Salvage Therapy; Tetrahydroisoquinolines; Trabectedin

2003

Other Studies

5 other study(ies) available for ecteinascidin 743 and Osteogenic Sarcoma

ArticleYear
Trabectedin suppresses osteosarcoma pulmonary metastasis in a mouse tumor xenograft model.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2022, Volume: 40, Issue:4

    Topics: Adolescent; Animals; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Heterografts; Humans; Lung Neoplasms; Mice; Neoplasm Metastasis; Osteosarcoma; Trabectedin

2022
Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2017, Sep-01, Volume: 23, Issue:17

    Topics: Bone Neoplasms; Cell Differentiation; Cell Line, Tumor; Cellular Reprogramming; Core Binding Factor Alpha 1 Subunit; Dioxoles; Humans; Immunotherapy; Lung Neoplasms; Osteosarcoma; Programmed Cell Death 1 Receptor; T-Lymphocytes; Tetrahydroisoquinolines; Trabectedin; Tumor Microenvironment; Tumor Suppressor Protein p53

2017
Trabectedin and irinotecan combination regresses a cisplatinum-resistant osteosarcoma in a patient-derived orthotopic xenograft nude-mouse model.
    Biochemical and biophysical research communications, 2019, May-28, Volume: 513, Issue:2

    Topics: Adolescent; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Humans; Irinotecan; Male; Mice, Nude; Osteosarcoma; Topoisomerase I Inhibitors; Trabectedin

2019
Major efficacy of trabectedin in 2 metastatic osteosarcoma patients with wild-type Asp1104 ERCC5 tumor status.
    Onkologie, 2013, Volume: 36, Issue:11

    Topics: Adolescent; Biomarkers, Tumor; Bone Neoplasms; Dioxoles; DNA-Binding Proteins; Endonucleases; Female; Genetic Markers; Humans; Male; Nuclear Proteins; Osteosarcoma; Polymorphism, Single Nucleotide; Tetrahydroisoquinolines; Trabectedin; Transcription Factors; Treatment Outcome; Young Adult

2013
Effectiveness of Ecteinascidin-743 against drug-sensitive and -resistant bone tumor cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:12

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neoplasms; Cell Differentiation; Dioxoles; Drug Resistance, Neoplasm; Humans; Inhibitory Concentration 50; Isoquinolines; Nuclear Proteins; Osteosarcoma; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Retinoblastoma Protein; Sarcoma, Ewing; Tetrahydroisoquinolines; Trabectedin; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2002